Loading company…
Primoris Therapeutics develops exosome-based treatments for wounds, hair loss, pneumonia and cancer.
Founded in 2019 and based in Gwangmyeong, Primoris Therapeutics develops treatments using function-enhanced exosome technology. Its work includes wound healing, pneumonia, lung cancer and hair loss therapies, as well as exosome and artificial nanovesicle drug delivery platforms. In February 2021, it raised KRW 3 billion in pre-Series A funding from BNH Investment, DAYLI Partners and Sneak Peek Investment.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in